ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Revenue

In the year 2025, ProQR Therapeutics had annual revenue of 16.35M EUR, down -16.36%. ProQR Therapeutics had revenue of 4.72M in the quarter ending December 31, 2025, with 6.14% growth.

• Revenue (ttm): 16.35M EUR
• Revenue Growth: -16.36%
• P/S Ratio: 9.30
• Revenue / Employee: 87,605 EUR
• Employees: 187
• Market Cap: 179.64M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.35M	-3.20M	-16.36%
Dec 31, 2024	19.55M	10.02M	105.20%
Dec 31, 2023	9.53M	5.17M	118.51%
Dec 31, 2022	4.36M	1.98M	83.31%
Dec 31, 2021	2.38M	-7.07M	-74.84%
Dec 31, 2020	9.45M	7.52M	388.98%
Dec 31, 2019	1.93M	-3.83M	-66.45%
Dec 31, 2018	5.76M	4.27M	285.35%
Dec 31, 2017	1.50M	-333.00K	-18.22%
Dec 31, 2016	1.83M	-1.41M	-43.49%
Dec 31, 2015	3.24M	2.92M	933.55%
Dec 31, 2014	313.00K	197.00K	169.83%
Dec 31, 2013	116.00K	-	-

Data Source: Fiscal.ai Last updated: Mar 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error